BTRC and neoplasm: Our results indicate that involvement of β-TrCP as E3 ligase in Cyclin D1 ubiquitination-dependent proteolysis is the mechanism in berberine′s inhibitory action on Cyclin D1 expression in HepG2 cells, and contributes partially to the anti-tumor action of berberine.